Bausch Health Companies Inc.: Irritable Bowel Syndrome trials

The registry lists 10 Irritable Bowel Syndrome studies with Bausch Health Companies Inc. as lead sponsor. 0 are open to participants now and 7 have results posted.

Phase 2 5Phase 3 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Long Term Safety Study of PlecanatideCompletedNCT02706483Phase 3Results posted
• Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)CompletedNCT02493452Phase 3Results posted
• The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)CompletedNCT01722318Phase 2Results posted
• Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment StudyCompletedNCT01543178Phase 3Results posted
• Mesalamine Granules for Irritable Bowel Syndrome (IBS) With DiarrheaCompletedNCT01177410Phase 2Results posted
• Rifaximin 3 Times/Day (TID) for Non-Constipation Irritable Bowel Syndrome (IBS)CompletedNCT00731679Phase 3Results posted
• Rifaximin 3 Times/Day (TID) for Non-Constipation Irritable Bowel Syndrome (IBS)CompletedNCT00724126Phase 3Results posted
• Diarrhea Predominant Irritable Bowel Syndrome in FemalesCompletedNCT00461526Phase 2
• Study to Assess the Efficacy and Safety of Rifaximin Administered BID in the Treatment of Patients With Diarrhea-Associated Irritable Bowel SyndromeCompletedNCT00269412Phase 2
• A Study of Crofelemer to Treat Diarrhea Irritable Bowel SyndromeCompletedNCT00101725Phase 2